Bert K. Lopansri

Bert K. Lopansri, MD

Languages spoken: English, Thai

  • Specialties

    Board Certification

    American Board of Medical Microbiology

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Infectious Diseases
    Board Certification
    American Board of Medical Microbiology

    Education history

    Other Training Clinical Investigation - University of Utah School of Medicine
    Infectious Disease - University of Utah School of Medicine Fellow
    Residency Internal Medicine - Loyola University Medical Center Resident
    Internal Medicine - Loyola University Medical Center Intern
    Professional Medical Medicine - Loyola University of Chicago M.D.
    Biology - University of Illinois at Urbana - Champaign B.S.

    Selected Publications

    Journal Article

    1. Ford CD, Hoda D, Lopansri BK, Parra M, Sharma P, Asch J (2023). An Algorithm Addressing the Problem of Overdiagnosis of Clostridioides difficile Infections in Hematopoietic Stem Cell Transplantation Recipients: Effects on C. difficile Infection Rates and Patient Outcomes. Transplant Cell Ther. (Read full article)
    2. Ambrose N, Amin A, Anderson B, Barrera-Oro J, Bertagnolli M, Campion F, Chow D, Danan R, DArinzo L, Drews A, Erlandson K, Fitzgerald K, Garcia M, Gaspar FW, Gong C, Hanna G, Jones S, Lopansri B, Musser J, OHoro J, Piantadosi S, Pritt B, Razonable RR, Roberts S, Sandmeyer S, Stein D, Vahidy F, Webb B, Yttri J (2023). Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes. JAMA Netw Open, 6(4), e239694. (Read full article)
    3. Gavina K, Franco LC, Robinson CM, Hymas W, Lei GS, Sinclair W, Hall T, Carlquist J, Lavik JP, Emery CL, Heaton PR, Hillyard D, Lopransi BK, Relich RF (2023). Standardization of SARS-CoV-2 Cycle Threshold Values: Multisite Investigation Evaluating Viral Quantitation across Multiple Commercial COVID-19 Detection Platforms. Microbiol Spectr, 11(1), e0447022. (Read full article)
    4. Ford CD, Lopansri BK, Coombs J, Gouw L, Asch J, Hoda D (2022). Extended spectrum cephalosporin resistant enterobacteriaceae carriage and infection in patients admitted with newly-diagnosed acute leukemia. Am J Infect Control, 51(2), 172-177. (Read full article)
    5. Tritle BJ, Watteyne R, Hickman A, Vento TJ, Lopansri BK, Collingridge DS, Veillette JJ (2021). No Implementation Without Representation: Real-Time Pharmacist Intervention Optimizes Rapid Diagnostic Tests for Bacteremia at a Small Community Hospital. Hosp Pharm, 57(3), 377-384. (Read full article)
    6. Ford CD, Lopansri BK, Coombs J, Gouw L, Asch J, Hoda D (2022). Extended spectrum cephalosporin resistant enterobacteriaceae carriage and infection in patients admitted with newly-diagnosed acute leukemia. Am J Infect Control, 51(2), 172-177. (Read full article)
    7. Eckman E, Laman JD, Fischer KF, Lopansri B, Martins TB, Hill HR, Kriesel JD (2021). Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria. J Mol Med (Berl), 99(10), 1399-1411. (Read full article)
    8. Peltan ID, Beesley SJ, Webb BJ, Lopansri BK, Sinclair W, Jacobs JR, Brown SM (2021). Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing. PLoS One, 16(5), e0251214. (Read full article)
    9. Riedel S, Halls J, Dutta S, Toraskar N, Lemon J, Carter K, Sinclair W, Lopansri BK, Styer AM, Wolk DM, Walker GT (2021). Clinical evaluation of the acuitas® AMR gene panel for rapid detection of bacteria and genotypic antibiotic resistance determinants. Diagn Microbiol Infect Dis, 100(4), 115383. (Read full article)
    10. Rubach MP, Mukemba JP, Florence SM, Lopansri BK, Hyland K, Simmons RA, Langelier C, Nakielny S, DeRisi JL, Yeo TW, Anstey NM, Weinberg JB, Mwaikambo ED, Granger DL (2021). Cerebrospinal fluid pterins, pterin-dependent neurotransmitters, and mortality in pediatric cerebral malaria. J Infect Dis, 224, 1432-1441. (Read full article)
    11. Webb BJ, Majers J, Healy R, Jones PB, Butler AM, Snow G, Forsyth S, Lopansri BK, Ford CD, Hoda D (2019). Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-Resistant Enterococcus Infection. Clin Infect Dis, 71(4), 960-967. (Read full article)
    12. Ford CD, Lopansri BK, Coombs J, Webb BJ, Asch J, Hoda D (2020). Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients? Transpl Infect Dis, 22(4), e13279. (Read full article)
    13. Webb BJ, Subramanian A, Lopansri B, Goodman B, Jones PB, Ferraro J, Stenehjem E, Brown SM (2020). Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection. Antimicrob Agents Chemother, 64(4). (Read full article)
    14. Peterson D, Barbeau B, McCaffrey K, Gruninger R, Eason J, Burnett C, Dunn A, Dimond M, Harbour J, Rossi A, Lopansri B, Dascomb K, Scribellito T, Moosman T, Saw L, Jones C, Belenky M, Marsden L, Niezgoda M, Gigante CM, Condori RE, Ellison JA, Orciari LA, Yager P, Bonwitt J, Whitehouse ER, Wallace RM (2020). Human Rabies - Utah, 2018. MMWR Morb Mortal Wkly Rep, 69(5), 121-124. (Read full article)
    15. Ford CD, Lopansri BK, Coombs J, Webb BJ, Nguyen A, Asch J, Hoda D (2019). Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes. Clin Transplant, 33(11), e13712. (Read full article)
    16. Ford CD, Coombs J, Stofer MG, Lopansri BK, Webb BJ, Ostronoff F, Asch J, Hoda D (2019). Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia. Infect Control Hosp Epidemiol, 40(7), 774-779. (Read full article)
    17. Ford CD, Lopansri BK, Webb BJ, Coombs J, Gouw L, Asch J, Hoda D (2018). Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes. Am J Infect Control, 47(4), 394-399. (Read full article)
    18. Walker GT, Quan J, Higgins SG, Toraskar N, Chang W, Saeed A, Sapiro V, Pitzer K, Whitfield N, Lopansri BK, Motyl M, Sahm D (2019). Predicting Antibiotic Resistance in Gram-Negative Bacilli from Resistance Genes. Antimicrob Agents Chemother, 63(4). (Read full article)
    19. Rubach MP, Zhang H, Florence SM, Mukemba JP, Kalingonji AR, Anstey NM, Yeo TW, Lopansri BK, Thompson JW, Mwaikambo ED, Young S, Millington DS, Weinberg JB, Granger DL (2019). Kinetic and Cross-Sectional Studies on the Genesis of Hypoargininemia in Severe Pediatric Plasmodium falciparum Malaria. Infect Immun, 87(4). (Read full article)
    20. Lopansri BK, Miller Iii RR, Burke JP, Levy M, Opal S, Rothman RE, DAlessio FR, Sidhaye VK, Balk R, Greenberg JA, Yoder M, Patel GP, Gilbert E, Afshar M, Parada JP, Martin GS, Esper AM, Kempker JA, Narasimhan M, Tsegaye A, Hahn S, Mayo P, McHugh L, Rapisarda A, Sampson D, Brandon RA, Seldon TA, Yager TD, Brandon RB (2019). Physician agreement on the diagnosis of sepsis in the intensive care unit: estimation of concordance and analysis of underlying factors in a multicenter cohort. J Intensive Care, 7, 13. (Read full article)
    21. Webb BJ, Brunner A, Lewis J, Ford CD, Lopansri BK (2018). Repurposing an Old Drug for a New Epidemic: Ursodeoxycholic Acid to Prevent Recurrent Clostridioides difficile Infection. Clin Infect Dis, 68(3), 498-500. (Read full article)
    22. Webb BJ, Healy R, Majers J, Burr Z, Gazdik M, Lopansri B, Hoda D, Petersen FB, Ford C (2016). Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation. Clin Infect Dis, 64(12), 1753-1759. (Read full article)
    23. Haydoura S, Wallentine J, Lopansri B, Ford CD, Saad D, Burke JP (2014). Disseminated histoplasmosis in allogeneic bone marrow transplant: a diagnosis not to be missed. Transpl Infect Dis, 16(5), 822-6. (Read full article)
    24. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, Price RN, Duffull SB, Celermajer DS, Anstey NM (2007). Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med, 204(11), 2693-704. (Read full article)
    25. Lopansri BK, Anstey NM, Stoddard GJ, Mwaikambo ED, Boutlis CS, Tjitra E, Maniboey H, Hobbs MR, Levesque MC, Weinberg JB, Granger DL (2006). Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications. Infect Immun, 74(6), 3355-9. (Read full article)

    Letter

    1. Lin L, Carlquist J, Sinclair W, Hall T, Lopansri BK, Bennett ST (2020). Experience With False-Positive Test Results on the TaqPath Real-Time Reverse Transcription-Polymerase Chain Reaction Coronavirus Disease 2019 (COVID-19) Testing Platform. [Letter to the editor]. Arch Pathol Lab Med, 145(3), 259-261. (Read full article)

  • News & Podcasts